Privacy Policy
Effective Date: June 29, 2026
Novastra Therapeutics, Inc. ("Novastra," "we," "us") respects your privacy. This Privacy Policy explains how we collect, use, and share information when you visit novastra.bio (the "Site") or contact us through it.
Information We Collect
When you contact us, we may collect the information you provide, including your name, email address, organization, and message. When you visit the Site, we and our service providers may automatically collect technical information such as your IP address, browser and device information, referring pages, and pages viewed, through cookies and similar technologies.
How We Use Information
We use information to:
-
respond to inquiries and business communications;
-
operate, secure, analyze, and improve the Site;
-
maintain records and protect our legal rights; and
-
comply with applicable law.
Cookies and Analytics
The Site may use cookies and similar technologies for essential functionality, analytics, and site improvement. Where required by applicable law, we seek consent before using non-essential cookies. You may also control cookies through your browser settings.
Legal Bases for Processing
Where the European Economic Area, United Kingdom, or similar data-protection laws apply, we process personal information based on our legitimate interests, your consent where required, compliance with legal obligations, or other lawful bases available under applicable law.
How We Share Information
We do not sell personal information. We may share information with service providers that support our Site and business operations, with professional advisers, when required by law, or when necessary to protect our rights, safety, and property.
Your Privacy Rights
Depending on your location, you may have rights to access, correct, delete, restrict, or obtain a copy of your personal information, object to certain processing, or withdraw consent. California residents may have rights under applicable California privacy laws, including rights to know, correct, and delete personal information and to opt out of any sale or sharing; the categories of personal information we collect are identifiers and internet or network activity, and Novastra does not sell personal information as that term is commonly understood. To submit a request, contact us using the details below. We may need to verify your identity before responding.
Retention and Security
We retain personal information only for as long as reasonably necessary for the purposes described in this Policy or as required by law. We use reasonable safeguards, but no method of transmission or storage is completely secure.
Children's Privacy
The Site is not directed to children, and we do not knowingly collect personal information from children through the Site.
Changes and Contact
We may update this Privacy Policy; the Effective Date above indicates when it was last revised. Privacy contact: partnerships@novastra.bio (subject line "Privacy").
Novastra Therapeutics, Inc., One Broadway, Cambridge, MA 02142, USA.
Terms of Use
Effective Date: June 29, 2026
Acceptance
By accessing or using novastra.bio, you agree to these Terms of Use. If you do not agree, do not use the site.
Informational Purpose Only
The site is provided for general informational purposes. Nothing on the site constitutes medical, scientific, investment, legal, or other professional advice; an offer or solicitation to buy or sell securities; or a recommendation regarding any treatment or course of action.
Investigational Products
Novastra's product candidates are investigational and have not been approved by the US Food and Drug Administration or any other regulatory authority for any use. Statements on the site should not be interpreted as establishing the safety or efficacy of any product candidate.
Intellectual Property
The site and its content, including text, graphics, logos, designs, and the OmniAntigen™ and XIRT™ names and marks, are owned by or licensed to Novastra and are protected by applicable intellectual-property laws. You may not reproduce, distribute, modify, or use site content without prior written permission, except as permitted by law.
Acceptable Use
You may not misuse the site, interfere with its operation or security, attempt unauthorized access, introduce malicious code, or use the site in violation of applicable law.
Third-Party Links
The site may link to third-party websites. Novastra does not control and is not responsible for third-party content, availability, security, or privacy practices. Accessing third-party sites is at your own risk.
Disclaimer of Warranties
The site is provided on an "as is" and "as available" basis, without warranties of any kind, express or implied, to the fullest extent permitted by law.
Limitation of Liability
To the fullest extent permitted by law, Novastra will not be liable for indirect, incidental, special, consequential, or punitive damages arising from or related to your use of the site. Where applicable law does not permit certain exclusions or limitations, liability will be limited to the maximum extent permitted by law.
Governing Law
These Terms are governed by the laws of the State of Delaware, without regard to conflict-of-laws principles.
Changes and Contact
We may update these Terms from time to time. Continued use of the site after an update constitutes acceptance to the extent permitted by law.
Contact: partnerships@novastra.bio
Forward-Looking Statement
This website contains forward-looking statements regarding Novastra Therapeutics, including statements about the development of its product candidates, the conduct and timing of clinical studies, anticipated regulatory milestones, and the company's strategic plans. Forward-looking statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Novastra undertakes no obligation to update them except as required by law. Novastra Therapeutics' product candidates are investigational and have not been approved by the US Food and Drug Administration or any other regulatory authority for any use. No conclusions regarding safety or efficacy should be drawn from the information on this website.
Accessibility Statement
Novastra Therapeutics is committed to providing a website that is accessible to people with disabilities. We aim to align the site with the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA and to improve accessibility as the site evolves.
If you encounter an accessibility barrier, contact partnerships@novastra.bio and describe the page and issue. We will review the request and work to provide access or an appropriate alternative.